ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine
(group practice)

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,463Medicare Part D Prescriptions Filled, Including Refills

Rank: 950 out of 5176

$805K Total Retail Price of All Prescriptions

Rank: 442 out of 5176

392 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 8,176 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

38% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$95 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
EVISTA 460 449 1 65
SIMVASTATIN 423 404 2 1
AMLODIPINE BESYLATE 314 295 3 2
LOSARTAN POTASSIUM 303 285 4 14
METFORMIN HCL ER 287 278 5 57
ATORVASTATIN CALCIUM 247 241 6 9
ATENOLOL 245 229 7 12
ALENDRONATE SODIUM 206 195 8 18
LIDODERM 190 190 9 59
METFORMIN HCL 187 180 10 7
ENALAPRIL MALEATE 166 158 11 22
JANUVIA 161 161 12 25
METOPROLOL SUCCINATE 159 154 13 11
PAROXETINE HCL 148 144 14 93
OMEPRAZOLE 148 139 14 3
GLIMEPIRIDE 137 137 16 37
FINASTERIDE 132 130 17 69
DOXAZOSIN MESYLATE 131 131 18 103
NEXIUM 130 130 19 16
CRESTOR 127 123 20 15
GABAPENTIN 126 115 21 21
LOVASTATIN 126 106 21 46
METOPROLOL TARTRATE 123 123 23 6
LEVOTHYROXINE SODIUM 113 112 24 4
ISOSORBIDE MONONITRATE ER 104 101 25 44
AMMONIUM LACTATE 102 94 26 91
DONEPEZIL HCL 99 99 27 28
BENICAR 94 94 28 100
TAMSULOSIN HCL 90 88 29 20
HYDROCHLOROTHIAZIDE 80 80 30 10
DIOVAN 79 79 31 19
LIDOCAINE 79 79 31 179
AMOXICILLIN 75 71 33 163
MECLIZINE HCL 74 74 34 81
LIPITOR 73 73 35 51
FLUTICASONE PROPIONATE 68 65 36 38
ULORIC 67 67 37 280
ONGLYZA 65 65 38 153
ACTOS 64 55 39 85
FUROSEMIDE 57 57 40 8
CARVEDILOL 55 55 41 24
SPIRIVA 53 53 42 54
LOSARTAN-HYDROCHLOROTHIAZIDE 53 50 42 35
ADVAIR DISKUS 53 51 42 32
FLUOCINONIDE 52 49 45 165
MELOXICAM 51 49 46 53
ZOLPIDEM TARTRATE 51 51 46 17
NAMENDA 50 50 48 47
ALLOPURINOL 50 46 48 41
HALOBETASOL PROPIONATE 50 49 48 445
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 13, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.